Document Detail


Acute decreases in serum potassium augment blood pressure.
MedLine Citation:
PMID:  7645536     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Potassium depletion is a risk factor for cardiovascular diseases, including hypertension, and frequently is encountered in patients with end-stage renal disease. Since the treatment of end-stage renal disease might result in K+ depletion and postdialysis hypokalemia, we investigated the relationship between acute K+ removal by hemodialysis and changes in blood pressure at the completion of treatment compared with predialysis and 1-hour postdialysis blood pressure. The effects of three different dialysate potassium concentrations ([K+]d; 1.0, 2.0, and 3.0 mmol/L) were investigated in 11 patients. Hemodialysis-induced K+ removal, serum [K+], total body K+, and blood pressure were measured. The use of 1.0, 2.0, or 3.0 mmol/L [K+]d resulted in the removal of 77.0 +/- 6.5, 54.5 +/- 7.9, and 42.5 +/- 9.9 mmol of K+ per treatment, respectively (P < 0.05, [K+]d 1.0 v [K+]d 3.0). Predialysis and postdialysis serum [K+] were 4.9 +/- 0.2 and 3.6 +/- 0.1 mEq/L for 1.0 mmol/L [K+]d, 5.1 +/- 0.3 and 3.9 +/- 0.1 mEq/L for 2.0 mmol/L [K+]d, and 5.3 +/- 0.3 and 4.2 +/- 0.2 mEq/L for 3.0 mmol/L [K+]d, respectively (P < 0.001 for each [K+]d). The baseline total body K+ corrected for gender, age, and race was 92% of predicted normal level and did not change significantly with the use of different [K+]d. Blood pressure decreased during hemodialysis as excess fluid was removed, regardless of [K+]d. Significant increases in blood pressure did occur 1 hour postdialysis compared with levels measured at the completion of treatment ("rebound hypertension") when hemodialysis was performed with 1.0 and 2.0 mmol/L, but not with 3.0 mmol/L [K+]d.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
G M Dolson; K J Ellis; M V Bernardo; R Prakash; H J Adrogué
Related Documents :
7546496 - Effect of dietary counselling on blood pressure and arterial plasma catecholamines in p...
3254766 - Effect of potassium supplementation on blood pressure and vasodilator mechanisms in spo...
1649866 - Does a digoxin-like substance participate in vascular and pressure control during dieta...
6530546 - A randomized trial on the effect of decreased dietary sodium intake on blood pressure i...
375296 - Prostaglandins, their intermediates and precursors: cardiovascular actions and regulato...
7211306 - Healing of ulcers on the feet correlated with distal blood pressure measurements in occ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  American journal of kidney diseases : the official journal of the National Kidney Foundation     Volume:  26     ISSN:  0272-6386     ISO Abbreviation:  Am. J. Kidney Dis.     Publication Date:  1995 Aug 
Date Detail:
Created Date:  1995-09-19     Completed Date:  1995-09-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8110075     Medline TA:  Am J Kidney Dis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  321-6     Citation Subset:  IM    
Affiliation:
Department of Medicine, Veterans Affairs Medical Center, Houston, TX 77030, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Pressure / physiology*
Humans
Hypertension / physiopathology
Kidney Failure, Chronic / physiopathology,  therapy
Male
Middle Aged
Potassium / blood*
Potassium Deficiency / physiopathology
Renal Dialysis
Chemical
Reg. No./Substance:
7440-09-7/Potassium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Trends in renal disease morbidity and mortality in the United States, 1979 to 1990.
Next Document:  Removal of iron dextran by hemodialysis: an in vitro study.